Israel Englander Sight Sciences, Inc. Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.13 - $7.15 $299,709 - $417,724	58,423 Added 24.56%	296,289 $1.98 Million
Q1 2024 May 15, 2024	BUY	$4.02 - $5.89 $756,350 - $1.11 Million	188,147 Added 378.42%	237,866 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $5.86 $16,469 - $74,814	12,767 Added 34.55%	49,719 $256,000
Q2 2023 Aug 14, 2023	SELL	$7.46 - $10.67 $2.24 Million - $3.2 Million	-299,960 Reduced 89.03%	36,952 $305,000
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $2.45 Million - $3.88 Million	290,527 Added 626.34%	336,912 $2.95 Million
Q4 2022 Feb 14, 2023	SELL	$5.58 - $13.94 $1.36 Million - $3.39 Million	-243,061 Reduced 83.97%	46,385 $566,000
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $1.68 Million - $3.15 Million	276,208 Added 2086.48%	289,446 $1.84 Million

21.3M

66.8K

13K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $130M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.